journal article·2022-11

Genome‐Wide Polygenic Score Predicts Large Number of High Risk Individuals in Monogenic Undiagnosed Young Onset Parkinson's Disease Patients from India

Prashanth Lingappa Kukkle, Thenral S. Geetha, Ruchi Chaudhary, Jarupon F. Sathirapongsasuti, Vinay Goyal, Rukmini Mridula Kandadai, Hrishikesh Kumar, Rupam Borgohain, Adreesh Mukherjee, Merina Oliver, Meeta Sunil, Mohammed Faizal Eeman Mootor, Shruti Kapil, Nitin Mandloi, Pettarusp M. Wadia, Ravi Yadav, Soaham Desai, Niraj Kumar, Atanu Biswas, Pramod Kumar Pal, Uday B. Muthane, Shymal Kumar Das, Sakthivel M. Sakthivel Murugan, Andrew S. Peterson, Eric W. Stawiski, Somasekar Seshagiri, Ravi Gupta, Vedam L. Ramprasad, Parkinson Research Alliance of India (PRAI)

Advanced Biology· Volume 6· Issue 11
Publisher page

Abstract

Abstract Parkinson's disease (PD) is a genetically heterogeneous neurodegenerative disease with poorly defined environmental influences. Genomic studies of PD patients have identified disease‐relevant monogenic genes, rare variants of significance, and polygenic risk‐associated variants. In this study, whole genome sequencing data from 90 young onset Parkinson's disease (YOPD) individuals are analyzed for both monogenic and polygenic risk. The genetic variant analysis identifies pathogenic/likely pathogenic variants in eight of the 90 individuals (8.8%). It includes large homozygous coding exon deletions in PRKN and SNV/InDels in VPS13C, PLA2G6, PINK1, SYNJ1, and GCH1. Eleven rare heterozygous GBA coding variants are also identified in 13 (14.4%) individuals. In 34 (56.6%) individuals, one or more variants of uncertain significance (VUS) in PD/PD‐relevant genes are observed. Though YOPD patients with a prioritized pathogenic variant show a low polygenic risk score (PRS), patients with prioritized VUS or no significant rare variants show an increased PRS odds ratio for PD. This study suggests that both significant rare variants and polygenic risk from common variants together may contribute to the genesis of PD. Further validation using a larger cohort of patients will confirm the interplay between monogenic and polygenic variants and their use in routine genetic PD diagnosis and risk assessment.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: CRISPR and Genetic Engineering · Genomics and Rare Diseases · Genomic variations and chromosomal abnormalities

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Neurology Manipal Hospital Miller Road Bangalore 560052 India

Department of Neurology Parkinson's Disease and Movement Disorders Clinic Bangalore 560010 India

Department of Neurology All India Institute of Medical Sciences Rishikesh 249201 India

Research and Diagnostics Department MedGenome Labs Pvt Ltd Bangalore 560099 India

Research Department MedGenome Inc. 348 Hatch Drive Foster City CA 94404 USA

Department of Neurology All India Institute of Medical Sciences (AIIMS) New Delhi 110608 India

Department of Neurology Medanta Hospital New Delhi 110047 India

Department of Neurology Medanta The Medicity Gurgaon 122006 India

Department of Neurology Nizams Institute of Medical Sciences (NIMS) Hyderabad 500082 India

Department of Neurology Institute of Neurosciences Kolkata Kolkata 700007 India

Department of Neurology Bangur Institute of Neurosciences and Institute of Post Graduate Medical Education and Research (IPGME&R) Kolkata 700020 India

Department of Neurology Jaslok Hospital and Research Centre Mumbai 400026 India

Department of Neurology National Institute of Mental Health and Neurosciences (NIMHANS) Bangalore 560029 India

Department of Neurology Shree Krishna Hospital and Pramukhswami Medical College Bhaikaka University Karamsad 388325 India

Department of Neurology Parkinson and Ageing Research Foundation Bangalore 560095 India

GenomeAsia 100K Foundation Foster City USA

Hyderabad 500084 India

References (75)

Show source-provided references
1. 10.1016/S1474-4422(19)30287-X10.1016/S1474-4422(19)30287-X ↗
2. 10.1002/mds.2515010.1002/mds.25150 ↗
3. 10.1002/ana.2368710.1002/ana.23687 ↗
4. 10.1038/s41588-019-0379-x10.1038/s41588-019-0379-x ↗
5. 10.1017/cjn.2021.4010.1017/cjn.2021.40 ↗
6. 10.3389/fneur.2020.0052410.3389/fneur.2020.00524 ↗
7. 10.1038/s41586-019-1310-410.1038/s41586-019-1310-4 ↗
8. 10.1093/hmg/ddv37610.1093/hmg/ddv376 ↗
9. 10.1111/cge.1312410.1111/cge.13124 ↗
10. 10.1038/ng.395510.1038/ng.3955 ↗
11. 10.1038/ng.304310.1038/ng.3043 ↗
12. 10.1016/S1474-4422(19)30320-510.1016/S1474-4422(19)30320-5 ↗
13. 10.1002/mdc3.1250110.1002/mdc3.12501 ↗
14. 10.1016/j.neurobiolaging.2017.01.01910.1016/j.neurobiolaging.2017.01.019 ↗
15. 10.1093/hmg/ddp01210.1093/hmg/ddp012 ↗
16. 10.1016/j.parkreldis.2020.07.01410.1016/j.parkreldis.2020.07.014 ↗
17. 10.1212/WNL.17.5.42710.1212/WNL.17.5.427 ↗
18. 10.1371/journal.pgen.100843210.1371/journal.pgen.1008432 ↗
19. 10.1038/s41586-019-1793-z10.1038/s41586-019-1793-z ↗
20. 10.1002/humu.2237210.1002/humu.22372 ↗
21. 10.1038/ng182610.1038/ng1826 ↗
22. 10.1002/mds.2322110.1002/mds.23221 ↗
23. 10.1111/j.1468-1331.2008.02356.x10.1111/j.1468-1331.2008.02356.x ↗
24. 10.1111/j.1468-1331.2011.03639.x10.1111/j.1468-1331.2011.03639.x ↗
25. 10.1002/mds.2735210.1002/mds.27352 ↗
26. 10.1002/ana.2025610.1002/ana.20256 ↗
27. 10.1002/mds.2093310.1002/mds.20933 ↗
28. 10.1212/WNL.0b013e3181e0f79c10.1212/WNL.0b013e3181e0f79c ↗
29. 10.1002/mds.2599410.1002/mds.25994 ↗
30. 10.1016/j.neurobiolaging.2020.03.00310.1016/j.neurobiolaging.2020.03.003 ↗
31. 10.3390/cells804036410.3390/cells8040364 ↗
32. 10.1186/s12881-019-0759-110.1186/s12881-019-0759-1 ↗
33. 10.1016/j.neurobiolaging.2019.12.02310.1016/j.neurobiolaging.2019.12.023 ↗
34. 10.1186/s13024-016-0097-010.1186/s13024-016-0097-0 ↗
35. 10.1093/nar/gkx115310.1093/nar/gkx1153 ↗
36. 10.1016/S0304-3940(98)00984-710.1016/S0304-3940(98)00984-7 ↗
37. 10.1007/s00415-009-0083-310.1007/s00415-009-0083-3 ↗
38. Patel M. · Nat. Rev. Neurol. · 2017 · 13 · 641
39. 10.1212/NXG.000000000000017710.1212/NXG.0000000000000177 ↗
40. 10.1016/j.ajhg.2010.10.00110.1016/j.ajhg.2010.10.001 ↗
41. 10.1126/science.126211010.1126/science.1262110 ↗
42. 10.1002/mds.2590410.1002/mds.25904 ↗
43. 10.1212/NXG.000000000000007310.1212/NXG.0000000000000073 ↗
44. 10.1016/j.jacc.2020.06.02410.1016/j.jacc.2020.06.024 ↗
45. 10.1016/j.nbd.2020.10478210.1016/j.nbd.2020.104782 ↗
46. 10.1126/science.276.5321.204510.1126/science.276.5321.2045 ↗
47. 10.1146/annurev-neuro-100720-03451810.1146/annurev-neuro-100720-034518 ↗
48. 10.1002/mds.2019410.1002/mds.20194 ↗
49. 10.1007/s10048-014-0406-010.1007/s10048-014-0406-0 ↗
50. 10.1002/ana.2477710.1002/ana.24777 ↗
51. 10.1212/01.wnl.0000304039.11891.2910.1212/01.wnl.0000304039.11891.29 ↗
52. 10.1002/ana.2478110.1002/ana.24781 ↗
53. 10.1016/j.parkreldis.2016.04.02410.1016/j.parkreldis.2016.04.024 ↗
54. 10.1016/j.parkreldis.2009.10.00510.1016/j.parkreldis.2009.10.005 ↗
55. 10.1016/j.parkreldis.2005.12.00410.1016/j.parkreldis.2005.12.004 ↗
56. 10.2174/1570159X1666618022216541810.2174/1570159X16666180222165418 ↗
57. 10.1016/j.neulet.2006.04.05210.1016/j.neulet.2006.04.052 ↗
58. 10.4103/0028-3886.7912510.4103/0028-3886.79125 ↗
59. 10.1016/j.expneurol.2016.03.02410.1016/j.expneurol.2016.03.024 ↗
60. 10.1093/brain/awh27610.1093/brain/awh276 ↗
61. 10.1038/s41467-020-17374-310.1038/s41467-020-17374-3 ↗
62. 10.1161/CIRCULATIONAHA.118.03565810.1161/CIRCULATIONAHA.118.035658 ↗
63. 10.3389/fnagi.2017.0002010.3389/fnagi.2017.00020 ↗
64. 10.1136/pgmj.2006.05475910.1136/pgmj.2006.054759 ↗
65. 10.1016/S1474-4422(17)30004-210.1016/S1474-4422(17)30004-2 ↗
66. 10.1093/nar/gky111310.1093/nar/gky1113 ↗
67. 10.1186/s13059-016-0974-410.1186/s13059-016-0974-4 ↗
68. 10.1093/bib/bbs01710.1093/bib/bbs017 ↗
69. 10.1093/bioinformatics/btv71010.1093/bioinformatics/btv710 ↗
70. 10.1093/nar/gky112010.1093/nar/gky1120 ↗
71. 10.1093/nar/gkw94310.1093/nar/gkw943 ↗
72. 10.1093/bioinformatics/btq55910.1093/bioinformatics/btq559 ↗
73. 10.1101/gr.094052.10910.1101/gr.094052.109 ↗
74. 10.1038/nature1539310.1038/nature15393 ↗
75. 10.1186/s12864-018-4489-010.1186/s12864-018-4489-0 ↗